Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FP.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FG.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.88SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.5.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.23.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JE.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.83SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GN.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GY.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HH.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HN.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.13.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JY.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.7.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DV.7.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used